Jacobs Levy Equity Management, Inc Cerus Corp Transaction History

Jacobs Levy Equity Management, Inc

  • $24.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 16, 2023
SELL
$1.5 - $3.07 $269,644 - $551,872
-179,763 Reduced 49.62%
182,549 $295,000
Q2 2023

Aug 14, 2023
BUY
$1.79 - $2.9 $648,538 - $1.05 Million
362,312 New
362,312 $891,000
Q1 2020

May 15, 2020
SELL
$2.87 - $5.49 $458,580 - $877,214
-159,784 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$3.84 - $4.86 $613,570 - $776,550
159,784 New
159,784 $674,000

Others Institutions Holding CERS

# of Institutions
156
Shares Held
148M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email